Harry Welten

Over the last 17 years, Mr. Welten was Chief Financial Officer of both public as well as venture capital financed biotech companies. During that time, he has raised more than CHF320 million through IPO, venture capital, M&A as well as debt offerings. He now serves as Chairman or Member on the Board of Directors of several biotechnology companies in Switzerland, Belgium and the USA. He has degrees in Banking, Finance and Economics as well as an MBA (hons.) from Columbia University, NY, USA.